Learn more

UKSH SCHLESWIG HOLSTEIN

Overview
  • Total Patents
    66
About

UKSH SCHLESWIG HOLSTEIN has a total of 66 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets medical technology, biotechnology and pharmaceuticals are UNIV GRAZ MED, EYE & ENT HOSPITAL OF FUDAN UNIV and SHANGHAI GENERAL HOSPITAL.

Patent filings in countries

World map showing UKSH SCHLESWIG HOLSTEINs patent filings in countries

Patent filings per year

Chart showing UKSH SCHLESWIG HOLSTEINs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sczakiel Georg 13
#2 Sievers Hans-Hinrich 7
#3 Blum Andreas 5
#4 Schroeder Jens-Michael 5
#5 Maser Edmund 5
#6 Mescalchin Alessandra 5
#7 Russlies Martin 4
#8 Ascherl Rudolf 4
#9 Barkmann Reinhard 4
#10 Glueer Claus-C 4

Latest patents

Publication Filing date Title
WO2013007346A1 Annuloplasty ring
DE102012007891A1 Method for controlling monitoring system for medical intensive care units for patient, involves actuating bed place with local alarm providing output unit, and receiving high level exhibiting sound sequences by sound receivers
DE102011122809B3 Device for measuring length variation in biological tissue in rotator cuff at knee joint of patient, has bifilar windings whose ends are fixed with active sensor coil, and passive sensor coil whose winding beginnings form supply terminals
DE102011118389A1 Monitoring system for medicinal intensive care unit for central monitoring of medicinal devices, has acoustic sensor per bed place for receiving alarm sounds emitted by acoustic alarm generators of diagnosis- and therapy units
EP2630496A1 Method for diagnosis of aneuploid colorectal tumours
DE102010025294A1 Method for isolating periodontal stem cells
DE102009024732A1 New oligonucleotide, comprising specified nucleotide sequences, is argonaute-1 expression inhibitor, useful for diagnosing or treating disorders or diseases e.g. angiogenesis, hematopoiesis, embryogenesis or tumors e.g. breast cancer
DE102009014693A1 Method for dosimetric evaluation of ionizing radiation acting on medical phantom, involves determining absorbed energy dose on basis of calibration data characterized between fluorescence of dosimeter liquid to absorbed energy dose
DE102009010942A1 Serine protease inhibitors for specific inhibition of tissue kallikreins
EP2077335A1 EXO1 promoter polymorphism associated with exceptional life expectancy in humans
DE102007059891A1 C-terminal lfapsoriasin fragments as antimicrobial peptides, their production and use
WO2008071169A2 Method for the production of specific inhibitors of 11-beta-hydroxysteroid dehydrogenase, in particular type 1 with basic nor-oleanan or nor-ursan frameworks
DE102007040718B3 Use of oligonucleotides with defined sequences to reduce mouse major satellite transcription
DE102006058207A1 New triterpene type compounds comprising a pentacyclic basic structure of nor-oleanan- or non-ursan -types are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent the diabetes, depression and glaucoma
DE102006058209A1 New triterpene type compounds comprising a pentacyclic basic unit of nor-oleanane- or nor-ursane-type, are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent diabetes, depression and glaucoma
DE102006032897B3 Tubular fixation element for minimally-invasive fascieography surgical procedure
DE102006029182B3 Larnyx mask with endotracheal tube comprising mask, shaft with tube-shaped section and guide rail and intubation tube fastened by pushing it through mask and pumping up tube cuff in tube-shaped section
DE102006023273B3 Arrangement to verifiably position a catheter serving as an endotracheal tube in the air tubes of a patient comprises a unit to determine the carbon dioxide content in a gas sample
DE102006007249A1 Method for the determination of bladder carcinomas of differentiation grade G2
WO2006012896A1 Cellular transfer of nucleic acid materials